Stocks to sell

A few months ago, the Federal Reserve was talking about “transitory” inflation. The governors at the Fed meant that while inflation was rising swiftly, it wasn’t going to last. But inflation kept rising at a brisk clip and the Fed started to be less sanguine about the transitory nature of inflation. It hedged by telling

Ocugen (NASDAQ:OCGN) is a small biotech firm. For years, it tried unsuccessfully to commercialize therapies for eye diseases. However, in 2020, it ended a Phase 3 trial on that front and pivoted to Covid-19. Its first effort in that regard, Covid-19 testing, totally failed to take off. The company is nothing if not persistent, however,

I fully understand why it’s very tempting to buy Alibaba (NASDAQ:BABA) stock at this point. The company’s shares have tumbled a great deal in the last six months, yet the company remains one of the biggest and most successful e-commerce players on the planet, and its cloud business is still growing rapidly. Source: BigTunaOnline /

Tech stocks are hot property in 2021 but that is not the case with Intel (NASDAQ:INTC) stock. Source: Pavel Kapysh / Shutterstock.com The stock started diving a long time ago and has continued to do so for the past few months. INTC stock managed to hit an all-time high of $68 in January 2020 and

Israeli online freelancer platform Fiverr (NYSE:FVRR) is the definition of a mixed bag. The company has some key strengths that are balanced out by some equally important weaknesses. I typically find it’s best to avoid companies like this unless their shares are trading at a very attractive valuation. In the case of FVRR stock, that

It is time for Redditors to rejoice. After battling it out with hedge funds for the better part of a year, we are finally at a point where most short sellers are skeptical of touching GameStop (NYSE:GME) stock. Source: Northfoto / Shutterstock.com The short interest percentage of the total float stands at 16.98%, as of

Zoom Video Communications (NASDAQ:ZM) was one of the prime beneficiaries of the coronavirus pandemic. It closed out 2020 with a colossal run rate of $3.5 million in revenues. However, judging from recent results, its top- and bottom-line growth are slowing as we inch closer to a post-pandemic reality. Moreover, ZM stock is incredibly overvalued based

On Oct. 5, InvestorPlace’s Louis Navellier argued that Ocugen (NASDAQ:OCGN) stock needs a catalyst for it to break free.  Source: shutterstock.com/PhotobyTawat One day earlier, Ocugen appeared to get not one but two catalysts, according to a regulatory filing. As a result, OCGN stock even traded 11% higher in pre-market Oct. 5 trading. Yet by the end

To put it succinctly, there isn’t very much making Lemonade (NYSE:LMND) stock attractive at present. Source: Stephanie L Sanchez / Shutterstock.com Yes, there’s news that the insurance company is launching a new service for pets. That will expand the company’s product mix beyond life, homeowners, and renters insurance. And Lemonade already announced a car insurance

When you have nearly 3 billion monthly active users, some things are bound to go wrong. As the adage goes, you can please some of the people all of the time, you can please all of the people some of the time, but you can’t please all of the people all of the time. That

A few months back, ChargePoint (NYSE:CHPT) stock had plenty of positive catalysts that were helping it move higher or, at the very least, hold steady. Not only  was the U.S. bipartisan Infrastructure bill helping to sustain buzz about the shares, but the market was highly favorable to speculative growth stocks. Source: YuniqueB / Shutterstock.com But

Boeing (NYSE:BA) stock has yet to recover from 2018. Source: Alex JW Robinson / Shutterstock.com When the 737-MAX scandal first overtook the company, investors were told to “buy the dip” at $320 per share. After all, BA stock traded at $440. It delivered dividends of more than $2 per share each quarter. Those who bought

Easily the most controversial country over the past year-and-a-half period, China is again making waves. This time, it has taken on the cryptocurrency phenomenon, banning its transactions and its mining operations. Unfortunately, that puts SOS Ltd (NYSE:SOS) stock in quite a bind. Source: Mark Agnor / Shutterstock.com Its own government is enemy No. 1. As

Investors who are still holding onto shares of ContextLogic (NASDAQ:WISH) stock should dump the stock now before there’s nothing left. Source: sdx15 / Shutterstock.com WISH stock plummeted 28% in the last month, bringing its total decline for the year to 71%. It’s flirting with the $5 mark, which would make it a penny stock. Shareholders

Hyliion Holdings Corp (NYSE:HYLN) is an electric vehicle (EV) stock that’s different. Instead of cars, Hyliion is developing technology to electrify Class 8 trucks. This is a huge potential market. As a result, HYLN stock surged last fall, with the prospect of a government push to electrify commercial transportation fleets. Source: Scharfsinn / Shutterstock.com However,

After Palantir (NYSE:PLTR) lost a major  government contract this year and is reportedly on the verge of losing another one, the longer-term outlook of PLTR stock remains negative. Source: Ascannio / Shutterstock.com The news indicates that Palantir could be at risk of losing additional, meaningful deals in the public sector. What’s more, the reports undermine

Cowen (NYSE:COWN) is a U.S.-based financial services firm. COWN stock had a tremendous run throughout late 2020 and into 2021 after the pandemic’s stock market craze. Source: shutterstock.com/CC7 Cowen stock has grown by more than 260% since March 2020, but it’s time for a reversal as markets seek stability. The notion is that financials will

My editors asked me to give my 2 cents about SmileDirectClub (NASDAQ:SDC), the direct-to-consumer medtech platform that’s supposed to make your smile look like a million bucks. Unfortunately, for IPO investors, SDC stock has been anything but a millionaire-maker since going public in September 2019 at $23 a share.  Source: Thamyris Salgueiro / Shutterstock.com SDC

Shares of veterinary health company Zomedica (NYSE:ZOM) skyrocketed earlier this year, but have since plunged more than 80% from their peak. Investors had high hopes that its point-of-care diagnostics system, Truforma, would gain a lot of traction fast. However, that hasn’t been the case, with the company managing a measly $29,817 in sales in the

While I could get into a complicated argument about Greenidge Generation (NASDAQ:GREE), I think my colleague Alex Sirois said it best and said it succinctly: “There is now no reason to be invested” in GREE stock following the underlying company’s merger with Support.com in mid-September. Source: Shutterstock Since the mid-September merger, Greenidge shares have done